encepp

Post-authorisation Safety Study of Tralokinumab Use in Pregnancy: An Observational Study Based on Electronic Healthcare Data

18/04/2023
20/09/2024
EU PAS number:
EUPAS104085
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Study results
Study report
Other information
ENCePP Seal
This study has been awarded the ENCePP seal
Conflicts of interest of investigators

Annex5_DoIForm_Rivero

English (903.69 KB - PDF) View document

DOIForms_all update_September 2024.pdf

English (6.46 MB - PDF) View document
Composition of steering group and observers

EUPAS104085_No steering group

English (68.37 KB - PDF) View document
Signed code of conduct

Annex3_Declaration_Rivero.pdf

English (129.75 KB - PDF) View document
Signed code of conduct checklist

Annex2_Checklist_Rivero.pdf

English (116.57 KB - PDF) View document
Signed checklist for study protocols

NIS-tralo-2178 protocol 2.0 final_ENCePP Checklist_Redacted.pdf

English (773.23 KB - PDF) View document